• Minicabecera4

Reoxcare reinforces its presence in the Spanish market at SEHER Congress

 MG 2959 web

From the 21st to the 23rd of February, the 8th SEHER Congress (Spanish Wound Society) was held in Madrid, and Histocell took part in this event, participating as an exhibitor, and holding a symposium within the scientific program.

The SEHER Congress is organised annually with the aim of serving as a meeting forum for all professionals dedicated to the management of different types of wounds. More than 550 people participated in this event, that presented a complete and innovative program, and featured prominent foreign speakers, from societies around the world, to share the latest advances in wound healing.

2019.02 - SEHER - Seminario

Many people visited our Reoxcare stand, among well-known industry leaders, users, and more than 150 visitors who had the opportunity to know the benefits of the use of the wound dressing, marketed in Spain in 2018. Reoxcare is available internationally in Colombia, Chile, Peru and Mexico in America, as well as the Netherlands and Italy in Europe, with a short-term expansion plan for Jordan, Saudi Arabia, Ecuador, Panama, Austria, Italy, Greece, Cyprus and Portugal.

A key of the success of Reoxcare wound dressing are its antioxidant components, which allow to fight the excess of ROS that cause healing delay. This was the topic of the symposium offered by Histocell, entitled “The control of oxidative stress as a key factor for the activation of complex wounds”. With the help of Santiago Roviralta as moderator, renowned specialists in the management of wounds such as Soledad Conde, Paco de Haro and Begoña Castro, CSO of Histocell, presented their experience with the product to nearly 200 people who attended the appointment.

Our scientific and commercial team is at your disposal to clarify any doubt about the product or its use, so do not hesitate to contact us at This email address is being protected from spambots. You need JavaScript enabled to view it. .


About Reoxcare

Reoxcare® is a dressing of natural origin, unique within the range of products so far used for the treatment of chronic wounds. With more than 30 preclinical and clinical studies carried out, Reoxcare® has demonstrated unique antioxidant properties and the ability to induce a natural healing in highly inflammatory environments, the main cause of the chronification of wounds such as ulcers of vascular origin, Diabetic foot ulcers or pressure ulcers. Chronic wounds are a serious health and economic problem worldwide. It is estimated that there are about 175 million new cases every year, including pressure ulcers, vascular or diabetic. 28 million people suffer from chronic wounds annually and the estimated market this year for the treatment of these injuries is more than 5,000 million euros.